University of North Carolina at Chapel Hill Lineberger Comprehensive Cancer Center is a clinical research site located in Chapel Hill, North Carolina, United States 27599.
Crixeo Clinical Trials Trust Score: 81/100 (GOOD). This profile has not yet been claimed by the site owner.
University of North Carolina at Chapel Hill Lineberger Comprehensive Cancer Center has participated in 16 clinical trials with 6 currently active.
Therapeutic areas: Acute Myeloid Leukemia, Epstein-Barr Virus+ Associated Post-transplant Lymphoproliferative Disease (EBV+ PTLD), Solid Organ Transplant Complications.
Sponsors: UNC Lineberger Comprehensive Cancer Center, Pierre Fabre Medicament, Dana-Farber Cancer Institute.
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in North Carolina · View every site in Chapel Hill
Trust Score: 81/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
University of North Carolina at Chapel Hill Lineberger Comprehensive Cancer Center has a Crixeo Trust Score of 81/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
University of North Carolina at Chapel Hill Lineberger Comprehensive Cancer Center has 16 clinical trials on record, with 6 currently active. Their work covers Acute Myeloid Leukemia, Epstein-Barr Virus+ Associated Post-transplant Lymphoproliferative Disease (EBV+ PTLD), Solid Organ Transplant Complications.
University of North Carolina at Chapel Hill Lineberger Comprehensive Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.